Issn Print: 0195-668X
Publication Date: 2018/06/07
Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.